Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

10.80
Delayed Data
As of Apr 25
 +0.20 / +1.89%
Today’s Change
7.33
Today|||52-Week Range
13.70
-11.11%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close10.60
Today’s open10.70
Day’s range10.60 - 10.98
Volume107,839
Average volume (3 months)254,640
Market cap$263.0M
Dividend yield--
Data as of 04/25/2017

Growth & Valuation

Earnings growth (last year)-22.42%
Earnings growth (this year)-24.69%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+4.22%
P/E ratioNM
Price/Sales10.44
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.15+2.65%
MTNBMatinas BioPharma Ho...-0.03-1.02%
OCULOcular Therapeutix I...-0.08-0.86%
NERVMinerva Neuroscience...+0.35+5.19%
Data as of 04/25/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$28.9M
Annual profit (last year)-$69.7M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Michael P. Smith
Corporate headquarters
Emeryville, California

Forecasts


Search for Jobs